These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 323465

  • 1. Potentiation of antitumor drug action by centrophenoxine: specificity.
    Sladek NE.
    J Pharmacol Exp Ther; 1977 May; 201(2):518-26. PubMed ID: 323465
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine.
    Sladek NE.
    J Pharmacol Exp Ther; 1977 Jan; 200(1):17-24. PubMed ID: 319221
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic activity of alkylating agents in the presence of centrophenoxine and its hydrolysis products.
    Sladek NE.
    J Pharmacol Exp Ther; 1977 Dec; 203(3):630-9. PubMed ID: 336870
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA, Holden SA, Herman TS, Epelbaum R, Pardee AB, Dezube B.
    Anticancer Res; 1991 Dec; 11(4):1555-60. PubMed ID: 1746913
    [Abstract] [Full Text] [Related]

  • 5. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E.
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [Abstract] [Full Text] [Related]

  • 6. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E, Teicher BA, Holden SA, Cathcart KN, Wang YY.
    Cancer Res; 1988 Nov 15; 48(22):6417-23. PubMed ID: 3180059
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxicity and induction of sister chromatid exchanges in human and rodent brain tumor cells treated with alkylating chemotherapeutic agents.
    Tokuda K, Bodell WJ.
    Cancer Res; 1988 Jun 01; 48(11):3100-5. PubMed ID: 2835151
    [Abstract] [Full Text] [Related]

  • 8. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA, Holden SA, Eder JP, Brann TW, Jones SM, Frei E.
    Cancer Res; 1989 Nov 01; 49(21):5994-8. PubMed ID: 2790813
    [Abstract] [Full Text] [Related]

  • 9. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA, Herman TS, Holden SA, Epelbaum R, Liu SD, Frei E.
    Cancer Res; 1991 Feb 01; 51(3):780-4. PubMed ID: 1988117
    [Abstract] [Full Text] [Related]

  • 10. Activity of quinone alkylating agents in quinone-resistant cells.
    Begleiter A, Leith MK.
    Cancer Res; 1990 May 15; 50(10):2872-6. PubMed ID: 1692249
    [Abstract] [Full Text] [Related]

  • 11. Some central nervous actions of centrophenoxine (Meclofenoxat) in animals.
    Safta L, Cuparencu B.
    Acta Biol Med Ger; 1978 May 15; 37(8):1255-9. PubMed ID: 34958
    [Abstract] [Full Text] [Related]

  • 12. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV, Eremeeva AA, Tereshin IM.
    Antibiotiki; 1977 May 15; 22(2):153-8. PubMed ID: 404957
    [No Abstract] [Full Text] [Related]

  • 13. Effect of centrophenoxine on human embryonic lung cells in culture [proceedings].
    Gill PJ, Hanson DM.
    Adv Exp Med Biol; 1978 May 15; 97():277-84. PubMed ID: 347902
    [No Abstract] [Full Text] [Related]

  • 14. Potentiation of antitumor activity of cyclophosphamide by centrophenoxine.
    Kanzawa F, Hoshi A, Tsuda S, Kuretani K.
    Gan; 1972 Aug 15; 63(4):409-13. PubMed ID: 4404224
    [No Abstract] [Full Text] [Related]

  • 15. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
    Nakagawa M, Yamaguchi T, Fukawa H, Ogata J, Komiyama S, Akiyama S, Kuwano M.
    Jpn J Cancer Res; 1985 Apr 15; 76(4):315-20. PubMed ID: 2408954
    [Abstract] [Full Text] [Related]

  • 16. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM.
    Cancer Treat Rep; 1976 Jun 15; 60(6):665-98. PubMed ID: 782694
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT, Shellard SA, Hosking LK, Dempke WC, Fichtinger-Schepman AM, Tone T, Scanlon KJ, Whelan RD.
    Cancer Res; 1992 Jun 01; 52(11):3110-8. PubMed ID: 1591724
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS, Prakash NJ, Rosenberger AL, Hagan AC, Lachmann PJ, Mayer GD.
    Cancer Res; 1984 Jul 01; 44(7):2799-802. PubMed ID: 6426786
    [Abstract] [Full Text] [Related]

  • 19. [Prolongation of the mitotic life span of diploid human glia cells in a quantitative cell culture system by centrophenoxine (author's transl)].
    Rodemann HP, Bayreuther K.
    Arzneimittelforschung; 1979 Jul 01; 29(1):124-9. PubMed ID: 375944
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents.
    Fingert HJ, Chang JD, Pardee AB.
    Cancer Res; 1986 May 01; 46(5):2463-7. PubMed ID: 3084068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.